Emavusertib

SI-7516

Emavusertib, >98% (HPLC)

CAS No. : [1801344-14-8]

Synonyms : CA-4948

IUPAC Name : (R)-N-(5-(3-Hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Emavusertib selectively inhibits IRAK4 and FLT3 with oral activity, suppressing NF‑κB/MyD88 signaling and lowering IL‑6 and IL‑10 production. These effects translate into anti‑inflammatory and anti‑proliferative responses, culminating in apoptosis and measurable antitumor activity in vivo.

References : Wiese M. D. et al.: Expert. Opin. Investig. Drugs, 29(5), 475-482, 2020; Guidetti F. et al.: J. Clin. Med., 12(2), 399, 2023; Parrondo R. D. et al.: Front. Immunol., 14, 1239082, 2023.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.